Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 38

1.

Effect of adipocyte-secreted factors on EpCAM+/CD133+ hepatic stem cell population.

Firtina Karagonlar Z, Koç D, Şahin E, Avci ST, Yilmaz M, Atabey N, Erdal E.

Biochem Biophys Res Commun. 2016 Jun 3;474(3):482-90. doi: 10.1016/j.bbrc.2016.04.137. Epub 2016 Apr 27.

PMID:
27131739
2.

Ezrin Enhances EGFR Signaling and Modulates Erlotinib Sensitivity in Non-Small Cell Lung Cancer Cells.

Saygideğer-Kont Y, Minas TZ, Jones H, Hour S, Çelik H, Temel I, Han J, Atabey N, Erkizan HV, Toretsky JA, Üren A.

Neoplasia. 2016 Feb;18(2):111-20. doi: 10.1016/j.neo.2016.01.002.

3.

Elevated hepatocyte growth factor expression as an autocrine c-Met activation mechanism in acquired resistance to sorafenib in hepatocellular carcinoma cells.

Firtina Karagonlar Z, Koc D, Iscan E, Erdal E, Atabey N.

Cancer Sci. 2016 Apr;107(4):407-16. doi: 10.1111/cas.12891. Epub 2016 Feb 23.

4.

Resveratrol Protects and Restores Endothelium-Dependent Relaxation in Hypercholesterolemic Rabbit Corpus Cavernosum.

Murat N, Korhan P, Kizer O, Evcim S, Kefi A, Demir Ö, Gidener S, Atabey N, Esen AA.

J Sex Med. 2016 Jan;13(1):12-21. doi: 10.1016/j.jsxm.2015.12.002.

PMID:
26755081
5.

Targeting c-Met in Cancer by MicroRNAs: Potential Therapeutic Applications in Hepatocellular Carcinoma.

Karagonlar ZF, Korhan P, Atabey N.

Drug Dev Res. 2015 Nov;76(7):357-67. doi: 10.1002/ddr.21274. Epub 2015 Sep 12.

PMID:
26363180
6.

Heparin treatment increases thioredoxin interacting protein expression in hepatocellular carcinoma cells.

Gunes A, Iscan E, Topel H, Avci ST, Gumustekin M, Erdal E, Atabey N.

Int J Biochem Cell Biol. 2015 Aug;65:169-81. doi: 10.1016/j.biocel.2015.05.025. Epub 2015 May 30.

PMID:
26037596
7.

Downregulation of VANGL1 inhibits cellular invasion rather than cell motility in hepatocellular carcinoma cells without stimulation.

Cetin GO, Toylu A, Atabey N, Sercan Z, Sakizli M.

Genet Test Mol Biomarkers. 2015 Jun;19(6):283-7. doi: 10.1089/gtmb.2015.0014. Epub 2015 Apr 15.

8.

Reciprocal activating crosstalk between c-Met and caveolin 1 promotes invasive phenotype in hepatocellular carcinoma.

Korhan P, Erdal E, Kandemiş E, Cokaklı M, Nart D, Yılmaz F, Can A, Atabey N.

PLoS One. 2014 Aug 22;9(8):e105278. doi: 10.1371/journal.pone.0105278. eCollection 2014.

9.

MiR-181a-5p is downregulated in hepatocellular carcinoma and suppresses motility, invasion and branching-morphogenesis by directly targeting c-Met.

Korhan P, Erdal E, Atabey N.

Biochem Biophys Res Commun. 2014 Aug 8;450(4):1304-12. doi: 10.1016/j.bbrc.2014.06.142. Epub 2014 Jul 21.

PMID:
25058462
10.

Active form of AKT controls cell proliferation and response to apoptosis in hepatocellular carcinoma.

Kunter I, Erdal E, Nart D, Yilmaz F, Karademir S, Sagol O, Atabey N.

Oncol Rep. 2014 Feb;31(2):573-80. doi: 10.3892/or.2013.2932. Epub 2013 Dec 16.

11.

Associations of VEGF/VEGF-receptor and HGF/c-Met promoter polymorphisms with progression/regression of retinopathy of prematurity.

Kaya M, Çokakli M, Berk AT, Yaman A, Yesilirmak D, Kumral A, Atabey N.

Curr Eye Res. 2013 Jan;38(1):137-42. doi: 10.3109/02713683.2012.731550. Epub 2012 Oct 24.

PMID:
23094709
12.

The levels of hepatocyte growth factor in serum and follicular fluid and the expression of c-Met in granulosa cells in patients with polycystic ovary syndrome.

Şahin N, Toylu A, Gülekli B, Doğan E, Kovali M, Atabey N.

Fertil Steril. 2013 Jan;99(1):264-9. doi: 10.1016/j.fertnstert.2012.08.059. Epub 2012 Oct 1.

PMID:
23036804
13.

Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesis.

Bozkaya G, Korhan P, Cokaklı M, Erdal E, Sağol O, Karademir S, Korch C, Atabey N.

Mol Cancer. 2012 Sep 11;11:64. doi: 10.1186/1476-4598-11-64.

14.

Heparin inhibits Hepatocyte Growth Factor induced motility and invasion of hepatocellular carcinoma cells through early growth response protein 1.

Ozen E, Gozukizil A, Erdal E, Uren A, Bottaro DP, Atabey N.

PLoS One. 2012;7(8):e42717. doi: 10.1371/journal.pone.0042717. Epub 2012 Aug 13.

15.

HGF/c-Met overexpressions, but not met mutation, correlates with progression of non-small cell lung cancer.

Gumustekin M, Kargi A, Bulut G, Gozukizil A, Ulukus C, Oztop I, Atabey N.

Pathol Oncol Res. 2012 Apr;18(2):209-18. doi: 10.1007/s12253-011-9430-7. Epub 2011 Jul 21.

PMID:
21779788
16.

Influence of follicular fluid GDF9 and BMP15 on embryo quality.

Gode F, Gulekli B, Dogan E, Korhan P, Dogan S, Bige O, Cimrin D, Atabey N.

Fertil Steril. 2011 Jun;95(7):2274-8. doi: 10.1016/j.fertnstert.2011.03.045. Epub 2011 Apr 15.

PMID:
21496799
17.

Filamin a mediates HGF/c-MET signaling in tumor cell migration.

Zhou AX, Toylu A, Nallapalli RK, Nilsson G, Atabey N, Heldin CH, Borén J, Bergo MO, Akyürek LM.

Int J Cancer. 2011 Feb 15;128(4):839-46. doi: 10.1002/ijc.25417.

18.

Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells.

Yuzugullu H, Benhaj K, Ozturk N, Senturk S, Celik E, Toylu A, Tasdemir N, Yilmaz M, Erdal E, Akcali KC, Atabey N, Ozturk M.

Mol Cancer. 2009 Oct 22;8:90. doi: 10.1186/1476-4598-8-90.

19.

Differential expression of Caveolin-1 in hepatocellular carcinoma: correlation with differentiation state, motility and invasion.

Cokakli M, Erdal E, Nart D, Yilmaz F, Sagol O, Kilic M, Karademir S, Atabey N.

BMC Cancer. 2009 Feb 24;9:65. doi: 10.1186/1471-2407-9-65.

20.

Long-term effects of GnRH agonist, GnRH antagonist, and estrogen plus progesterone treatment on apoptosis related genes in rat ovary.

Saatli B, Kizildag S, Posaci C, Dogan E, Koyuncuoglu M, Ulukus EC, Atabey N.

Fertil Steril. 2009 May;91(5 Suppl):2006-11. doi: 10.1016/j.fertnstert.2008.07.1728. Epub 2008 Sep 30.

PMID:
18829022
Items per page

Supplemental Content

Loading ...
Write to the Help Desk